Inspection Readiness & Mock Audits

Aligning Post-Mock Action Tracking With TMF, QMS and Risk-Based Quality Management Aligning Post-Mock Action Tracking With TMF, QMS and Risk-Based Quality Management In the realm of clinical trials, the importance of rigorous oversight cannot be overstated. The landscape of clinical research continues to evolve, bringing with it new regulations, methodologies, and expectations for maintaining high-quality…

Read More “Aligning Post-Mock Action Tracking With TMF, QMS and Risk-Based Quality Management” »

Common GCP Findings Linked to Weak Post-Mock Action Tracking—and How to Prevent Them Common GCP Findings Linked to Weak Post-Mock Action Tracking—and How to Prevent Them In the complex world of clinical trials, especially within the framework of phase 3b clinical trials, maintaining compliance with ICH-GCP regulations is paramount. One critical aspect often overlooked is…

Read More “Common GCP Findings Linked to Weak Post-Mock Action Tracking—and How to Prevent Them” »

Post-Mock Action Tracking in Practice: Step-by-Step Guide for Clinical Quality Leaders Post-Mock Action Tracking in Practice: Step-by-Step Guide for Clinical Quality Leaders In the context of clinical trials, maintaining inspection readiness is crucial. A vital component of this readiness is the effective management of post-mock action tracking. As clinical operations, regulatory affairs, and medical affairs…

Read More “Post-Mock Action Tracking in Practice: Step-by-Step Guide for Clinical Quality Leaders” »

How to Design Post-Mock Action Tracking That Stands Up to FDA, EMA and MHRA Scrutiny How to Design Post-Mock Action Tracking That Stands Up to FDA, EMA and MHRA Scrutiny In an ever-evolving landscape of clinical research, ensuring compliance with regulatory standards is paramount, especially in the context of post-mock audits. This comprehensive guide outlines…

Read More “How to Design Post-Mock Action Tracking That Stands Up to FDA, EMA and MHRA Scrutiny” »

Post-Mock Action Tracking: End-to-End Blueprint for Health Authority Inspections Post-Mock Action Tracking: End-to-End Blueprint for Health Authority Inspections In today’s evolving landscape of clinical research, ensuring inspection readiness is critical for the successful completion of clinical trials. Health authorities, including the FDA, EMA, and MHRA, have increased scrutiny on clinical trials, making it imperative for…

Read More “Post-Mock Action Tracking: End-to-End Blueprint for Health Authority Inspections” »

Integrating Post-Mock Action Tracking With CAPA, Training and Change Control Integrating Post-Mock Action Tracking With CAPA, Training and Change Control In the complex landscape of clinical trials, especially within the frameworks established by ICH-GCP, FDA, EMA, and MHRA, maintaining inspection readiness is crucial. This guide aims to provide clinical operations, regulatory affairs, and medical affairs…

Read More “Integrating Post-Mock Action Tracking With CAPA, Training and Change Control” »

Case Studies: Post-Mock Action Tracking That Turned High-Risk Programs Inspection-Ready In the realm of clinical trials, ensuring regulatory compliance and inspection readiness is paramount, particularly for programs classified as high-risk. This article serves as a detailed tutorial on post-mock action tracking, providing case studies that illustrate how clinical research organizations (CROs) can effectively prepare for…

Read More “Case Studies: Post-Mock Action Tracking That Turned High-Risk Programs Inspection-Ready” »

KRIs, KPIs and Heatmaps to Monitor Post-Mock Action Tracking Performance KRIs, KPIs and Heatmaps to Monitor Post-Mock Action Tracking Performance The success of clinical trials is often dependent on robust Monitoring Key Results Indicators (KRIs), Key Performance Indicators (KPIs), and effective use of heatmaps to track post-mock action performance. This tutorial aims to provide clinical…

Read More “KRIs, KPIs and Heatmaps to Monitor Post-Mock Action Tracking Performance” »